Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2023

Mar 3, 2023

31971_dirs_2023-03-03_c327e51a-652c-411b-8a37-d313bc6f1388.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2023-03-01

Reporting Person: Jonas Daniel S (Special Counsel & Corp Secy)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-01 Common Stock M 2500 Acquired 14784 Direct
2023-03-01 Common Stock F 736 $96.16 Disposed 14048 Direct
2023-03-02 Common Stock M 5400 $59.96 Acquired 19448 Direct
2023-03-02 Common Stock S 5400 $96.245 Disposed 14048 Direct
2023-03-02 Common Stock M 5000 $78.76 Acquired 19048 Direct
2023-03-02 Common Stock S 5000 $96.0762 Disposed 14048 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-03-01 Rsus (restricted Stock Units) $0 M 2500 Disposed 2032-03-01 Common Stock (2500) Direct
2023-03-01 Rsus (restricted Stock Units) $0 A 3000 Acquired 2033-03-01 Common Stock (3000) Direct
2023-03-02 Options To Purchase Common Stock $59.96 M 5400 Disposed 2028-03-01 Common Stock (5400) Direct
2023-03-02 Options To Purchase Common Stock $78.76 M 5000 Disposed 2029-03-01 Common Stock (5000) Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.03 to $96.24. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting 100% after a one year period.

F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting in equal amounts (1000 units) over a three year period.

F4: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

F5: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period